×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Neurogene concludes merger deal with Neoleukin Therapeutics
Pharmaceutical Technology
Neurogene has concluded its merger deal with Neoleukin Therapeutics to develop genetic therapies for complex neurological ailments.
5 months ago
Neoleukin Therapeutics (NLTX) Looks Good: Stock Adds 9.4% in Session
Yahoo Movies UK
Neoleukin Therapeutics, Inc. NLTX was a big mover last session, as the company saw its shares rise more than 9% on the day.
1 week ago
Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million
Business Wire
Neurogene Inc. (NASDAQ: NGNE) (“Neurogene”), a clinical-stage company founded to bring life-changing genetic medicines to patients and...
5 months ago
Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split
Yahoo Finance
SEATTLE, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” or the “Company” (NASDAQ:NLTX), a biopharmaceutical...
5 months ago
Neoleukin, old ending: De novo protein player lays off 70% of staff, searches for strategic alternative
Fierce Biotech
The end is near for Neoleukin Therapeutics. Months after laying off 40% of its staff and dropping its lead candidate, the de novo protein...
14 months ago
Neurogene and Neoleukin Announce Definitive Merger Agreement
GlobeNewswire
Proposed merger to create Nasdaq-listed biotech company focused on advancing Neurogene's differentiated portfolio of genetic medicines for...
10 months ago
Fenwick Represents Neoleukin in Merger Agreement with… | Fenwick
Fenwick & West LLP
Fenwick is representing Neoleukin Therapeutics, Inc. (NASDAQ: NLTX) in its definitive merger agreement with Neurogene Inc., a clinical-stage...
10 months ago
Neoleukin to merge with Neurogene for $200m in cash reserves
Pharmaceutical Technology
Neurogene and Neoleukin Therapeutics have entered a definitive agreement to merge as part of an all-stock transaction.
10 months ago
Biomed Industries, Inc. Offers to acquire Neoleukin Therapeutics, Inc. (NASDAQ:NLTX)
AccessWire
Biomed Industries, Inc. Offers to acquire Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) ... Biomed Industries, Inc. ... SAN JOSE, CA / ACCESSWIRE / May...
12 months ago
Redmile Group, LLC Boosts Stake in Neoleukin Therapeutics Inc
Yahoo Finance
San Francisco-based investment firm, Redmile Group, LLC (Trades, Portfolio), recently increased its holdings in Neoleukin Therapeutics Inc...
10 months ago